UltraGreen.ai Limited (SGX:UGS)

Singapore · Delayed Price · Currency is SGD

1.510

0.00 (0.00%)

At close: Aug 6, 2026

Market Cap	1.66B
Revenue (ttm)	177.43M +91.5%
Net Income	97.27M +129.0%
EPS	0.25 -99.7%
Shares Out	n/a
PE Ratio	17.09
Forward PE	15.20
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,600
Open	1.510
Previous Close	1.510
Day's Range	1.490 - 1.520
52-Week Range	1.480 - 1.840
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About UltraGreen.ai

UltraGreen.ai Limited manufactures and sells Indocyanine Green (ICG) pharmaceutical products in the United States and internationally. It provides diagnostic imaging analytics and software solutions. The company also develops software for real-time quantification of blood perfusion during surgery, including PerfusionWorks quantification software for tissue perfusion, lymphatic mapping, and margin assessment. In addition, it offers products, such as ICG, the IC-Flow Imaging System and the UltraGreen Data Platform and other technologies related t... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2024

Country Singapore

Stock Exchange Singapore Exchange

Ticker Symbol UGS

Financial Performance

In 2025, UltraGreen.ai's revenue was $137.94 million, an increase of 27.70% compared to the previous year's $108.02 million. Earnings were $75.63 million, an increase of 35.15%.

Financial numbers in USD Financial Statements